AUPH Competitors & Alternatives
Compare Aurinia Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
AUPH
Main Stock$17.88
Tradestie Score
65
Market Cap
$1.50B
P/E Ratio
8.1
Revenue Growth
0.2%
Analyst Upside
-4.9%
Top Competitors
225 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ARQT
Arcutis Biotherapeutics, Inc. Common Stock
|
$26.27
|
$2.37B | - | 56 | Compare |
|
APGE
Apogee Therapeutics, Inc. Common Stock
|
$132.88
|
$2.35B | - | 61 | Compare |
|
IBRX
ImmunityBio, Inc. Common Stock
|
$7.32
|
$2.34B | - | 65 | Compare |
|
IRON
Disc Medicine, Inc. Common Stock
|
$70.45
|
$2.33B | - | 59 | Compare |
|
AGIO
Agios Pharmaceuticals, Inc.
|
$35.59
|
$2.33B | - | 52 | Compare |
|
GLPG
Galapagos NV
|
$27.73
|
$2.31B | 5.1 | 59 | Compare |
|
RXRX
Recursion Pharmaceuticals, Inc. Class A Common Stock
|
$3.16
|
$2.23B | - | 49 | Compare |
|
ADPT
Adaptive Biotechnologies Corporation Common Stock
|
$17.23
|
$2.22B | - | 55 | Compare |
|
TVTX
Travere Therapeutics, Inc. Common Stock
|
$55.95
|
$2.21B | - | 64 | Compare |
|
DNLI
Denali Therapeutics Inc. Common Stock
|
$24.77
|
$2.18B | - | 61 | Compare |
More AUPH Analysis
Data updated: Jun 24, 2026 | Industry: Biotechnology (SIC 2834)
225 stocks in this industry